Published on
Jul 26, 2025
FDA delays approval decision for Bayer menopause therapy
The Food and Drug Administration has delayed its review of a Bayer therapy for hot flashes related to menopause, telling the drugmaker it needs additional to review the company’s application. In a Friday statement, Bayer said the FDA did not raise any …
Source:
BioPharma Dive
-
Pending
